Isoprenoid biosynthesis in hereditary periodic fever syndromes and inflammation
about
Molecular mechanisms involved in farnesol-induced apoptosisNew insights into the enigma of immunoglobulin D.Statin therapy and autoimmune disease: from protein prenylation to immunomodulationIsoprenoids, small GTPases and Alzheimer's disease.Simvastatin treatment enhances NMDAR-mediated synaptic transmission by upregulating the surface distribution of the GluN2B subunit.Pathogenesis of familial periodic fever syndromes or hereditary autoinflammatory syndromes.Developments in the scientific and clinical understanding of autoinflammatory disordersThe Central Role of Anti-IL-1 Blockade in the Treatment of Monogenic and Multi-Factorial Autoinflammatory Diseases.Sufficient production of geranylgeraniol is required to maintain endotoxin tolerance in macrophages.Recurrent febrile syndromes: what a rheumatologist needs to know.Nummular keratopathy in a patient with Hyper-IgD Syndrome.Defects in cholesterol synthesis genes in mouse and in humans: lessons for drug development and safer treatments.Clinical immunology review series: An approach to the patient with a periodic fever syndrome.The analytical determination of isoprenoid intermediates from the mevalonate pathway.Inheritance of autoinflammatory diseases: shifting paradigms and nomenclature.Mevalonate kinase deficiency in two sisters with therapeutic response to anakinra: case report and review of the literature.The clinical spectrum of inherited diseases involved in the synthesis and remodeling of complex lipids. A tentative overview.Association of Long-Term Atorvastatin with Escalated Stroke-Induced Neuroinflammation in Rats.Compromized geranylgeranylation of RhoA and Rac1 in mevalonate kinase deficiency.Detection of nonsterol isoprenoids by HPLC-MS/MS.Hyper-IgD and periodic fever syndrome (HIDS) due to compound heterozygosity for G336S and V377I in a 44-year-old patient with a 27-year history of fever.Farnesyl pyrophosphate regulates adipocyte functions as an endogenous PPARγ agonist.Novel mutations causing hyperimmunoglobulin D and periodic fever syndrome.Clinical and genetic heterogeneity among Spanish patients with recurrent autoinflammatory syndromes associated with the CIAS1/PYPAF1/NALP3 gene.MVK mutations and associated clinical features in Italian patients affected with autoinflammatory disorders and recurrent fever.Musculoskeletal symptoms in patients with cryopyrin-associated periodic syndromes: a large database study.Decreased cholesterol levels reflect a consumption of anti-inflammatory isoprenoids associated with an impaired control of inflammation in a mouse model of mevalonate kinase deficiency.Anti-interleukin 6 receptor therapy for hyper-IgD syndrome.Statins and modulation of oxidative stress.Dietary supplementation with geranylgeraniol suppresses lipopolysaccharide-induced inflammation via inhibition of nuclear factor-κB activation in rats.Farnesol, an isoprenoid, improves metabolic abnormalities in mice via both PPARα-dependent and -independent pathways.
P2860
Q24655100-604953DA-70DA-463A-B6C2-8D1256898360Q27687277-96823810-06D4-4CCC-B78F-ECFC1EACBC9CQ28236647-123544AD-2BAC-42C3-B188-83B3114E9EB2Q33915441-9204789F-AA3A-489C-9FC3-514A691F8880Q34081527-16195C66-DEA6-436B-9C8C-D5F7D1B9A4F3Q34560380-71DC63D9-65EA-4E96-A1C8-407A3ECE9646Q37207033-D642091A-4B67-4099-BA44-C2F1948B87A3Q37270409-06D271CA-0853-4DDE-ABE4-6F379F6C9DF3Q37305397-2765A94B-89B5-4836-9D70-7D5583C44099Q37468460-11987779-1E06-4455-8718-AFD05F237EF5Q37572943-7186EAB4-C8ED-45D3-9A86-672A96893524Q37830049-16843B22-6472-4DE5-942E-C05EA606F619Q37898725-9F304AC8-825B-43A1-9973-8EE051D0DACAQ37905648-503030E4-50B5-45C8-8ED0-3884CD4F4589Q38093826-EB0710CF-A1E4-4838-88EC-230FFEF46097Q38188458-08F826A6-3679-4D0A-8705-F633EEB75ED5Q38270108-1C9CA430-BEF1-47C0-B09A-F89DF2D7944EQ39474081-A8679BB7-DDBE-47D9-9FB5-12D0B778B1C8Q39659972-1432E376-412D-401C-8129-7B3A1A1BFBD7Q39941512-F8835F7D-BAE6-4445-AE93-217754C2322BQ40078299-7D076609-980F-44B4-821C-7E6415380655Q40237087-D4514802-6CE8-4526-97B7-637DE755F6E6Q40277829-7A5F4F80-95FF-45AC-99B0-A386B18925F8Q40519235-D68C770F-B81E-4B08-AD3C-7F97BB3C4EA7Q40521342-8A47A0BD-D68E-49EE-895F-01336461721EQ40657289-5AD90A6A-0929-4F02-9147-D78D32939515Q43154533-B301CB38-8513-4D39-9EE0-F0B35AD3FB56Q43184639-249D9007-42CB-4367-B78C-9688929E1C79Q43215640-EA2BB2AF-DD83-4058-8063-C8B6317C33DDQ43555831-022022C3-14C0-4D71-AB09-E2F3BF2BF38EQ53224130-53E91A41-E1CB-4DD4-A24C-74C136C14AF4
P2860
Isoprenoid biosynthesis in hereditary periodic fever syndromes and inflammation
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Isoprenoid biosynthesis in hereditary periodic fever syndromes and inflammation
@ast
Isoprenoid biosynthesis in hereditary periodic fever syndromes and inflammation
@en
Isoprenoid biosynthesis in hereditary periodic fever syndromes and inflammation
@nl
type
label
Isoprenoid biosynthesis in hereditary periodic fever syndromes and inflammation
@ast
Isoprenoid biosynthesis in hereditary periodic fever syndromes and inflammation
@en
Isoprenoid biosynthesis in hereditary periodic fever syndromes and inflammation
@nl
prefLabel
Isoprenoid biosynthesis in hereditary periodic fever syndromes and inflammation
@ast
Isoprenoid biosynthesis in hereditary periodic fever syndromes and inflammation
@en
Isoprenoid biosynthesis in hereditary periodic fever syndromes and inflammation
@nl
P2093
P1476
Isoprenoid biosynthesis in hereditary periodic fever syndromes and inflammation
@en
P2093
H R Waterham
S M Houten
P2888
P304
P356
10.1007/S00018-003-2296-4
P407
P577
2003-06-01T00:00:00Z